Literature DB >> 23447576

Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model.

Paul K Newton1, Jeremy Mason, Kelly Bethel, Lyudmila Bazhenova, Jorge Nieva, Larry Norton, Peter Kuhn.   

Abstract

The classic view of metastatic cancer progression is that it is a unidirectional process initiated at the primary tumor site, progressing to variably distant metastatic sites in a fairly predictable, although not perfectly understood, fashion. A Markov chain Monte Carlo mathematical approach can determine a pathway diagram that classifies metastatic tumors as "spreaders" or "sponges" and orders the timescales of progression from site to site. In light of recent experimental evidence highlighting the potential significance of self-seeding of primary tumors, we use a Markov chain Monte Carlo (MCMC) approach, based on large autopsy data sets, to quantify the stochastic, systemic, and often multidirectional aspects of cancer progression. We quantify three types of multidirectional mechanisms of progression: (i) self-seeding of the primary tumor, (ii) reseeding of the primary tumor from a metastatic site (primary reseeding), and (iii) reseeding of metastatic tumors (metastasis reseeding). The model shows that the combined characteristics of the primary and the first metastatic site to which it spreads largely determine the future pathways and timescales of systemic disease.

Entities:  

Mesh:

Year:  2013        PMID: 23447576      PMCID: PMC3644026          DOI: 10.1158/0008-5472.CAN-12-4488

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Predicting the course of Gompertzian growth.

Authors:  L Norton; R Simon; H D Brereton; A E Bogden
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

2.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  The human disease network.

Authors:  Kwang-Il Goh; Michael E Cusick; David Valle; Barton Childs; Marc Vidal; Albert-László Barabási
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

4.  A Gompertzian model of human breast cancer growth.

Authors:  L Norton
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

5.  Liver resection for colorectal metastases.

Authors:  Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

6.  Modeling cancer progression via pathway dependencies.

Authors:  Elena J Edelman; Justin Guinney; Jen-Tsan Chi; Phillip G Febbo; Sayan Mukherjee
Journal:  PLoS Comput Biol       Date:  2008-02       Impact factor: 4.475

7.  Tumor self-seeding by circulating cancer cells.

Authors:  Mi-Young Kim; Thordur Oskarsson; Swarnali Acharyya; Don X Nguyen; Xiang H-F Zhang; Larry Norton; Joan Massagué
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

8.  Metastatic patterns of cancers: results from a large autopsy study.

Authors:  Guy Disibio; Samuel W French
Journal:  Arch Pathol Lab Med       Date:  2008-06       Impact factor: 5.534

9.  Are metastases from metastases clinical relevant? Computer modelling of cancer spread in a case of hepatocellular carcinoma.

Authors:  Anja Bethge; Udo Schumacher; Andreas Wree; Gero Wedemann
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

10.  A stochastic Markov chain model to describe lung cancer growth and metastasis.

Authors:  Paul K Newton; Jeremy Mason; Kelly Bethel; Lyudmila A Bazhenova; Jorge Nieva; Peter Kuhn
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more
  31 in total

Review 1.  Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.

Authors:  Andrea K Miyahira; Joshua M Lang; Robert B Den; Isla P Garraway; Tamara L Lotan; Ashley E Ross; Tanya Stoyanova; Steve Y Cho; Jonathan W Simons; Kenneth J Pienta; Howard R Soule
Journal:  Prostate       Date:  2015-10-19       Impact factor: 4.104

2.  Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes.

Authors:  Mark Robertson-Tessi; Robert J Gillies; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

3.  Liver-directed conversion therapy in metastatic colon cancer.

Authors:  Alexandra Snyder; Nancy Kemeny; Ali Shamseddine; Ashwaq Al-Olayan; Fadi El-Merhi; David P Kelsen; Faek Jamali; Mustafa Sidani; Deborah Mukherji; Mahmoud El-Naghy; Eileen M O'Reilly; Leonard B Saltz; Ghassan K Abou-Alfa
Journal:  J Gastrointest Oncol       Date:  2015-06

4.  The prisoner's dilemma as a cancer model.

Authors:  Jeffrey West; Zaki Hasnain; Jeremy Mason; Paul K Newton
Journal:  Converg Sci Phys Oncol       Date:  2016-07-04

5.  Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy.

Authors:  Chen Qian; Asurayya Worrede-Mahdi; Fei Shen; Anthony DiNatale; Ramanpreet Kaur; Qiang Zhang; Massimo Cristofanilli; Olimpia Meucci; Alessandro Fatatis
Journal:  Mol Cancer Res       Date:  2018-08-16       Impact factor: 5.852

6.  Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.

Authors:  Amanda Jane Williams Gibson; Haocheng Li; Adrijana D'Silva; Roxana A Tudor; Anifat A Elegbede; Shannon Mary Otsuka; D Gwyn Bebb; Winson Y Cheung
Journal:  Med Oncol       Date:  2018-08-02       Impact factor: 3.064

7.  Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer.

Authors:  Gino In; Jeremy Mason; Sonia Lin; Paul K Newton; Peter Kuhn; Jorge Nieva
Journal:  Converg Sci Phys Oncol       Date:  2017-07-13

Review 8.  The mathematics of cancer: integrating quantitative models.

Authors:  Philipp M Altrock; Lin L Liu; Franziska Michor
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

Review 9.  Adrenal metastases in lung cancer: clinical implications of a mathematical model.

Authors:  Lyudmila Bazhenova; Paul Newton; Jeremy Mason; Kelly Bethel; Jorge Nieva; Peter Kuhn
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

10.  Modeling cancer-immune responses to therapy.

Authors:  L G dePillis; A Eladdadi; A E Radunskaya
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-04       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.